QRS Duration Is a Predictor of Adverse Outcomes in Heart Failure With Preserved Ejection Fraction

Keyphrases

• Aborted Cardiac Arrest 10%
• Adverse Clinical Outcomes 10%
• Adverse Outcomes 20%
• Aldosterone Antagonists 20%
• Cardiac Function 10%
• Cardiovascular Mortality 10%
• Clinical Outcomes 10%
• Clinical Syndromes 10%
• Conduction Abnormalities 10%
• Dichotomous Variables 10%
• Georgia 10%
• Heart Failure 20%
• Heart Failure with Preserved Ejection Fraction (HFpEF) 100%
• HF Hospitalization 30%
• High Risk 10%
• Linear Relation 10%
• Multivariate Analysis 10%
• North America 10%
• Predictors of Adverse Outcomes 100%
• Preserved Systolic Function 10%
• QRS Duration 100%
• Separation Analysis 10%
• South America 10%
• Spironolactone 20%
• TOPCAT 20%

Medicine and Dentistry

• Adverse Outcome 100%
• Aldosterone Antagonist 20%
• Cardiovascular System 10%
• Clinical Syndrome 10%
• Cohort Analysis 20%
• Congestive Heart Failure 20%
• Heart Arrest 10%
• Heart Failure with Preserved Ejection Fraction 100%
• Heart Function 10%
• Multivariate Analysis 10%
• Post-Hoc Analysis 10%
• Primary Outcome 40%
• QRS Interval 100%
• Spironolactone 20%
• Systolic Function 10%

Pharmacology, Toxicology and Pharmaceutical Science

• Adverse Outcome 100%
• Aldosterone Antagonist 50%
• Cohort Study 50%
• Congestive Heart Failure 50%
• Heart Arrest 25%
• Heart Failure with Preserved Ejection Fraction 100%
• Spironolactone 50%
• Syndrome 25%